Canada vs Japan: Proportion of isolates with decreased susceptibility or resistance
Canada
1.4
in 2020
Japan
3.7
in 2020
Canada rank
7th
Japan rank
5th
Proportion of isolates with decreased susceptibility or resistance over time
- Canada
- Japan
How they compare
Japan currently reports 3.7 against 1.4 in Canada, a difference of 2.3.
That makes Japan's figure about 2.6 times Canada's.
The two have swapped places 2 times across 11 shared years of data; in 2009 it was Japan ahead.
Canada ranks 7th and Japan ranks 5th of 52 countries.
Japan has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Canada | Japan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 3.09 | 20.35 | 17.26 | Japan |
| 2010s | 3.56 | 14.95 | 11.39 | Japan |
| 2020s | 1.4 | 3.7 | 2.3 | Japan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of isolates with decreased susceptibility or resistance, Canada or Japan?
- Japan, at 3.7 against 1.4 in Canada as of 2020.
- What is the difference in proportion of isolates with decreased susceptibility or resistance between Canada and Japan?
- 2.3, with Japan ahead.
- How many years of comparable data are there for Canada and Japan?
- 11 years are reported by both, from 2009 to 2020.
- How do Canada and Japan rank globally for proportion of isolates with decreased susceptibility or resistance?
- Canada ranks 7th and Japan ranks 5th of 52 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Proportion of isolates with decreased susceptibility or resistance (DS/R) to ceftriaxone reported to WHO-GASP. Statizoid refreshes it automatically from the source and publishes the full history for both places.